Complete DiGeorge Syndrome: Clinical Trials

3 trials for Complete DiGeorge Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 21Completed 1

Follow Complete DiGeorge Syndrome: new trials by email Literature Review of Complete DiGeorge Syndrome trials Research Report on Complete DiGeorge Syndrome

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I/II Thymus Transplantation With Immunosuppression #950
Cultured Thymus Tissue for Implantation (CTTI), Cultured Thymus Tissue Implantation and Parental Parathyroid Transplantation, Blood Draw - DiGeorge Anomaly, Complete DiGeorge Anomaly
Phase 1 / Phase 2CompletedSumitomo Pharma Switzerland GmbH142005-12-192022-03-25
Parathyroid and Thymus Transplantation in DiGeorge #931
Thymus/Parathyroid Transplantation - DiGeorge Syndrome, Hypoparathyroidism
Phase 1CompletedSumitomo Pharma Switzerland GmbH252005-01-012022-04-04
Thymus Transplantation With Immunosuppression
Thymus Tissue for Transplantation - DiGeorge Syndrome, DiGeorge Anomaly
Phase 1CompletedSumitomo Pharma Switzerland GmbH152002-07-012022-04-04

Narrower conditions

DiGeorge Syndrome (3)  ·  Thymic aplasia (3)  ·  Hypoparathyroidism (2)  ·  Immunologic Deficiency Syndromes (2)  ·  Hypocalcemia (1)

Broader conditions

22q11 Deletion Syndrome (3)  ·  Abnormalities, Multiple (3)  ·  Cardiovascular Abnormalities (3)  ·  Cardiovascular Diseases (3)  ·  Chromosome Disorders (3)  ·  Congenital Abnormalities (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Craniofacial Abnormalities (3)  ·  Endocrine System Diseases (3)  ·  Genetic Diseases, Inborn (3)  ·  Heart Defects, Congenital (3)  ·  Heart Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Lymphatic Abnormalities (3)  ·  Lymphatic Diseases (3)

Interventions

Thymus Extracts (2)  ·  Antilymphocyte Serum (1)  ·  Blood Specimen Collection (1)  ·  Cyclosporine (1)  ·  Cyclosporins (1)  ·  Daclizumab (1)  ·  Drug Implants (1)  ·  Methylprednisolone (1)  ·  Mycophenolic Acid (1)  ·  Phlebotomy (1)  ·  Prednisolone (1)  ·  Steroids (1)  ·  Tacrolimus (1)  ·  Transplantation (1)  ·  thymoglobulin (1)

Sponsors

Sumitomo Pharma Switzerland GmbH (3)

Countries

United States (3)

Top investigators

M. Louise Markert, MD, PhD (3)

Results publications

PMID 18035553, PMID 18424759, PMID 18557726, PMID 19066739, PMID 20236866, PMID 15100156, PMID 17284531, PMID 23607606, PMID 15100681, PMID 18155964, PMID 18333898, PMID 20978268, PMID 22590644

NIH funding

K12HD043494 (3), R01AI047040 (3), R01AI054843 (3), R56AI047040 (2)